Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Completed · Phase 3

Conditions studied: Peanut Allergy

In brief

Open-label, follow-up study for subjects who completed the EPITOPE study.

Key facts

Study ID
NCT03859700
Run by
DBV Technologies
People needed
304
Starts
2018-12-06
Expected to finish
2025-05-13
Last updated by the study team
2025-06-06

Who can join

Age: 2 and older, up to 5. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.